SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 101.37 |
| Enterprise Value ($M) | 99.79 |
| Book Value ($M) | 4.14 |
| Book Value / Share | 0.24 |
| Price / Book | 24.49 |
| NCAV ($M) | -13.70 |
| NCAV / Share | -0.79 |
| Price / NCAV | -7.40 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.16 |
| Return on Assets (ROA) | -1.15 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.48 |
| Current Ratio | 0.80 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.98 |
| Assets | 25.82 |
| Liabilities | 21.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,948 | 10,927 | 54.43 | |
| 417 | 2,571 | 16.22 | |
| 625 | 3,837 | 16.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AVTE – Aerovate Therapeutics, Inc. | AXSM – Axsome Therapeutics, Inc. |
| BCAB – BioAtla, Inc. | BTMD – biote Corp. |
| CADL – Candel Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io